PubRank

Serena Pellegatta

Author PubWeight™ 24.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 2012 5.09
2 The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet 2013 2.89
3 The MET oncogene is a functional marker of a glioblastoma stem cell subtype. Cancer Res 2012 1.21
4 NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 2012 1.15
5 Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma. Cancer Res 2014 1.00
6 DNA damage in mammalian neural stem cells leads to astrocytic differentiation mediated by BMP2 signaling through JAK-STAT. Stem Cell Reports 2013 0.91
7 A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells. PLoS One 2012 0.91
8 FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration. Oncotarget 2012 0.90
9 Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan. PLoS One 2013 0.89
10 Reelin affects chain-migration and differentiation of neural precursor cells. Mol Cell Neurosci 2009 0.89
11 A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment. Cancer Immunol Immunother 2011 0.89
12 Immunotherapy for glioma: getting closer to the clinical arena? Curr Opin Neurol 2011 0.88
13 DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence. Oncologist 2011 0.85
14 Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma. Acta Neuropathol Commun 2015 0.84
15 Rai is a new regulator of neural progenitor migration and glioblastoma invasion. Stem Cells 2012 0.83
16 Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity. Oncoimmunology 2012 0.83
17 Perspectives for immunotherapy in glioblastoma treatment. Curr Opin Oncol 2014 0.82
18 An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma. PLoS One 2012 0.81
19 Novel mechanisms and approaches in immunotherapy for brain tumors. Discov Med 2015 0.78
20 Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres. Mol Cancer 2013 0.77
21 The potential of stem cells for the treatment of brain tumors and globoid cell leukodystrophy. Cytotechnology 2003 0.75